Treatment of hepatitis-associated aplastic anemia with high-dose cyclophosphamide.
about
Hepatitis associated aplastic anemia: a reviewIntensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages.Severe Aplastic Anemia following Acute Hepatitis from Toxic Liver Injury: Literature Review and Case Report of a Successful Outcome.High-dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia.
P2860
Treatment of hepatitis-associated aplastic anemia with high-dose cyclophosphamide.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Treatment of hepatitis-associated aplastic anemia with high-dose cyclophosphamide.
@en
Treatment of hepatitis-associated aplastic anemia with high-dose cyclophosphamide.
@nl
type
label
Treatment of hepatitis-associated aplastic anemia with high-dose cyclophosphamide.
@en
Treatment of hepatitis-associated aplastic anemia with high-dose cyclophosphamide.
@nl
prefLabel
Treatment of hepatitis-associated aplastic anemia with high-dose cyclophosphamide.
@en
Treatment of hepatitis-associated aplastic anemia with high-dose cyclophosphamide.
@nl
P2093
P2860
P356
P1476
Treatment of hepatitis-associated aplastic anemia with high-dose cyclophosphamide.
@en
P2093
Allen R Chen
David M Loeb
Linda M Resar
Meghan A Higman
Patricia A DeRusso
Richard J Jones
Robert A Brodsky
William J Savage
P2860
P304
P356
10.1002/PBC.21143
P577
2007-12-01T00:00:00Z